The Manufacturers Life Insurance Company Has $2.88 Million Stock Holdings in Hamilton Lane Incorporated (NASDAQ:HLNE)

The Manufacturers Life Insurance Company boosted its position in shares of Hamilton Lane Incorporated (NASDAQ:HLNE) by 8.4% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 23,265 shares of the company’s stock after purchasing an additional 1,810 shares during the period. The Manufacturers Life Insurance Company’s holdings in Hamilton Lane were worth $2,875,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Signaturefd LLC increased its stake in shares of Hamilton Lane by 13.1% in the second quarter. Signaturefd LLC now owns 629 shares of the company’s stock valued at $78,000 after buying an additional 73 shares in the last quarter. EFG Asset Management North America Corp. grew its holdings in Hamilton Lane by 0.5% during the 2nd quarter. EFG Asset Management North America Corp. now owns 17,185 shares of the company’s stock worth $2,125,000 after acquiring an additional 81 shares during the period. Rhumbline Advisers raised its position in shares of Hamilton Lane by 0.4% during the 2nd quarter. Rhumbline Advisers now owns 55,451 shares of the company’s stock valued at $6,853,000 after acquiring an additional 208 shares during the last quarter. Xponance Inc. lifted its stake in shares of Hamilton Lane by 9.5% in the 2nd quarter. Xponance Inc. now owns 2,435 shares of the company’s stock valued at $301,000 after purchasing an additional 211 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Hamilton Lane by 3.0% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,340 shares of the company’s stock valued at $1,031,000 after buying an additional 242 shares during the period. 97.40% of the stock is currently owned by institutional investors and hedge funds.

Hamilton Lane Price Performance

NASDAQ:HLNE opened at $173.01 on Wednesday. The stock’s 50-day simple moving average is $151.77 and its 200 day simple moving average is $131.92. Hamilton Lane Incorporated has a 52-week low of $78.66 and a 52-week high of $175.06. The company has a debt-to-equity ratio of 0.27, a quick ratio of 2.72 and a current ratio of 2.72. The company has a market cap of $9.34 billion, a P/E ratio of 46.89 and a beta of 1.19.

Hamilton Lane (NASDAQ:HLNE) last released its earnings results on Tuesday, August 6th. The company reported $1.51 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.41. Hamilton Lane had a net margin of 26.99% and a return on equity of 34.36%. The business had revenue of $196.73 million during the quarter, compared to analysts’ expectations of $149.84 million. During the same period last year, the business earned $0.94 earnings per share. As a group, sell-side analysts forecast that Hamilton Lane Incorporated will post 4.88 EPS for the current fiscal year.

Hamilton Lane Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 4th. Investors of record on Monday, September 16th were issued a dividend of $0.49 per share. This represents a $1.96 dividend on an annualized basis and a yield of 1.13%. The ex-dividend date was Monday, September 16th. Hamilton Lane’s payout ratio is currently 53.12%.

Analysts Set New Price Targets

HLNE has been the subject of several analyst reports. UBS Group upped their price target on Hamilton Lane from $122.00 to $150.00 and gave the company a “neutral” rating in a research note on Wednesday, August 21st. The Goldman Sachs Group boosted their target price on Hamilton Lane from $139.00 to $147.00 and gave the company a “neutral” rating in a research note on Thursday, October 3rd. Wells Fargo & Company started coverage on Hamilton Lane in a report on Thursday, September 12th. They set an “equal weight” rating and a $156.00 target price for the company. JPMorgan Chase & Co. upped their price objective on Hamilton Lane from $120.00 to $134.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 7th. Finally, Keefe, Bruyette & Woods lifted their target price on Hamilton Lane from $135.00 to $145.00 and gave the company a “market perform” rating in a research report on Wednesday, August 7th. Seven research analysts have rated the stock with a hold rating, According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $143.00.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.